Singapore markets closed
Straits Times Index
3,307.90 -6.15 (-0.19%) Nikkei
38,946.93 -122.75 (-0.31%) Hang Seng
19,220.62 -415.60 (-2.12%) FTSE 100
8,416.45 -7.75 (-0.09%) Bitcoin USD
69,948.31 +2,212.00 (+3.27%) CMC Crypto 200
1,522.61 +34.07 (+2.29%)
Propanc Biopharma, Inc. (PPCB)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 12:10PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 33.89k |
| Enterprise value | 959.93k |
| Trailing P/E | 0.00 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 1.82 |
| 52-week change 3 | -99.36% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 0.2625 |
| 52-week low 3 | 0.0006 |
| 50-day moving average 3 | 0.0018 |
| 200-day moving average 3 | 0.0142 |
Share statistics
| Avg vol (3-month) 3 | 5.85M |
| Avg vol (10-day) 3 | 8.3M |
| Shares outstanding 5 | 52.14M |
| Implied shares outstanding 6 | 167.98M |
| Float 8 | 52.14M |
| % held by insiders 1 | 1.38% |
| % held by institutions 1 | 0.00% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 19 Nov 2020 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:1000 |
| Last split date 3 | 19 Nov 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Jun 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -518.35% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -1.45M |
| Net income avi to common (ttm) | -2.73M |
| Diluted EPS (ttm) | 0.2400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 71.65k |
| Total cash per share (mrq) | 0 |
| Total debt (mrq) | 1.02M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.06 |
| Book value per share (mrq) | -0.10 |
Cash flow statement
| Operating cash flow (ttm) | -943.05k |
| Levered free cash flow (ttm) | -436.39k |
© 2024 Yahoo. All rights reserved.